Kevin Fay, MD

He/Him/His
Renal Electrolyte and Hypertension
Accepting new patients
Sees patients age 18 and up
Penn Renal Electrolyte and Hypertension University City
Schedule onlineCall 800-789-7366
Headshot of Kevin Fay, MD
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Medicine (Renal-Electrolyte and Hypertension)

My education and training

  • Medical School: Ross University School of Medicine
  • Residency: Henry Ford Hospital
  • Fellowship: University of Pennsylvania Health System
  • Fellowship: Thomas Jefferson University Hospital

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: On the medical staff, but does not have privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Penn Medicine Rittenhouse Long-Term Acute Care Hospital
  • Lancaster General Hospital
  • Princeton Medical Center: Has privileges to treat patients in the hospital.
  • Chester County Hospital: Has privileges to treat patients in the hospital.
Dr. Fay is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Kevin S. Fay and Debbie L. Cohen Aldosteronism , Ferri's Clinical Advisor 2022: 2021,103-104

Fay KS, Cohen DL. Resistant Hypertension in People With CKD: A Review , Am J Kidney Dis, 77(1): 2021,110-121

Rao B, Franzo-Romain M, Fay K, Whitlow K, Alam A. An unusual suspect for acute kidney injury in an end-stage liver disease patient: cryoglobulinemic glomerulonephritis , Abstract and Poster Presentation, 39th Annual Meeting of the Society of General Internal Medicine, Hollywood, FL.: 2016

Fay K, Gentile J, Mohyi M, Hrabec D, Bradley P Socioeconomic disparities in completion of open access colonoscopy. , Abstract and Oral Presentation, Henry Ford Hospital 23rd Medical Education Research Forum, Detroit, MI.: 2016

Veine DM, Yao H, Stafford DR, Fay KS, Livant DL. A D-amino acid containing peptide as a potent, noncovalent inhibitor of α5β1 integrin in human prostate cancer invasion and lung colonization , Clin Exp Metastasis, 31(4): 2014,379-93

Livant D, Yao H, Veine D, Fay K. The PHSCN peptide as a highly potent inhibitor of basement membrane invasion in vitro and lung colonization in nude mice by metastatic human prostate cancer cells , Abstract and Poster Presentation, American Association for Cancer Research 103rd Annual Meeting, Chicago, IL: 2012

Yao H, Zeng ZZ, Fay KS, Veine DM, Staszewski ED, Morgan M, Wilder-Romans K, Williams TM, Spalding AC, Ben-Josef E, Livant DL. Role of α(5)β(1) Integrin Up-regulation in Radiation-Induced Invasion by Human Pancreatic Cancer Cells , Transl Oncol, 4(5): 2011,282-92

Yao H, Veine DM, Fay KS, Staszewski ED, Zeng ZZ, Livant DL. The PHSCN dendrimer as a more potent inhibitor of human breast cancer cell invasion, extravasation, and lung colony formation , Breast Cancer Res Treat, 125(2): 2011,363-75

View all publications